Filing Flows › Corcept Therapeutics (CORT) › Recalls, complaints & regulation
Corcept Therapeutics (CORT): clinical trials
Corcept Therapeutics (CORT) beyond its filings: 6 active clinical trials.
Corcept Therapeutics' latest quarter
Corcept Therapeutics, Q3 2026: revenue $340M (+64% year over year), operating margin 33.7%, net earnings $127M, operating cash flow $143M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Corcept Therapeutics have?
6 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.